Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Therapeuticsmd Inc (TXMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,213,188
  • Shares Outstanding, K 237,880
  • Annual Sales, $ 16,780 K
  • Annual Income, $ -76,930 K
  • 36-Month Beta 1.40
  • Price/Sales 72.31
  • Price/Cash Flow N/A
  • Price/Book 8.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.17
  • Number of Estimates 4
  • High Estimate -0.13
  • Low Estimate -0.22
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -70.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.30 +13.26%
on 10/30/18
5.95 -18.15%
on 10/17/18
-1.10 (-18.43%)
since 10/16/18
3-Month
4.30 +13.26%
on 10/30/18
6.94 -29.83%
on 09/21/18
-0.68 (-12.25%)
since 08/16/18
52-Week
4.30 +13.26%
on 10/30/18
7.66 -36.42%
on 06/08/18
-1.03 (-17.46%)
since 11/16/17

Most Recent Stories

More News
TherapeuticsMD Announces Participation in Three Upcoming Investor Conferences

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the company will participate in three upcoming healthcare investor conferences. Chief Executive...

TXMD : 4.87 (-4.51%)
TherapeuticsMD to Report Third Quarter 2018 Financial Results on November 7, 2018

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that it will report its third quarter 2018 financial results on Wednesday, November 7, 2018,...

TXMD : 4.87 (-4.51%)
TherapeuticsMD (TXMD) Q3 Earnings Preview: What to Watch Ahead of the Release

TherapeuticsMD (TXMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TXMD : 4.87 (-4.51%)
Thinking about buying stock in Apple, International Business Machines, Square Incorporated, TherapeuticsMD Inc or Yulong Eco-Materials?

InvestorsObserver issues critical PriceWatch Alerts for AAPL, IBM, SQ, TXMD, and YECO.

YECO : 5.10 (+0.79%)
AAPL : 193.53 (+1.11%)
IBM : 121.57 (+0.11%)
YECOF : 0.0500 (+117.39%)
TXMD : 4.87 (-4.51%)
SQ : 70.59 (-4.09%)
Variant Pharmaceuticals Enhances Its Board of Directors with Three New Members

Variant Pharmaceuticals, Inc, a clinical stage orphan drug company developing first-in-class drugs for patients with rare diseases, announced today appointments of three new Board members, Robert (Rob)...

TXMD : 4.87 (-4.51%)
TherapeuticsMD Enters Into Label Discussions for TX-001HR

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative women's healthcare company, today announced that the Company has entered into discussions with the U.S. Food and Drug Administration (FDA)...

TXMD : 4.87 (-4.51%)
Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options

Investors need to pay close attention to TherapeuticsMD (TXMD) stock based on the movements in the options market lately.

TXMD : 4.87 (-4.51%)
TherapeuticsMD to Present at 2018 Cantor Global Healthcare Conference

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative women's healthcare company, today announced that the company will participate in the 2018 Cantor Global Healthcare Conference being held...

TXMD : 4.87 (-4.51%)
TherapeuticsMD Announces the FDA has Granted Annovera(TM) Marketing Exclusivity as a New Chemical Entity

TherapeuticsMD, Inc.(NASDAQ: TXMD), an innovative women's healthcare company, today announcedthat Annovera(TM)(segesterone acetateand ethinyl estradiol vaginal system) has been granted marketing...

TXMD : 4.87 (-4.51%)
Undervalued Cannabis and Biotech Stocks

HENDERSON, NV / ACCESSWIRE / September 18, 2018 / We have discovered a very interesting biotechnology company ENDV (Endonovo Therapeutics, Inc.), has an FDA cleared product, and is flying under the radar....

NXTTF : 1.1300 (-6.61%)
ENDV : 0.0335 (+1.52%)
OPK : 3.56 (+0.85%)
INO : 5.12 (+1.79%)
TXMD : 4.87 (-4.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade TXMD with:

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

2nd Resistance Point 5.38
1st Resistance Point 5.12
Last Price 4.87
1st Support Level 4.74
2nd Support Level 4.62

See More

52-Week High 7.66
Fibonacci 61.8% 6.38
Fibonacci 50% 5.98
Fibonacci 38.2% 5.58
Last Price 4.87
52-Week Low 4.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar